A new report in the journal JAMA Surgery has suggested that urologists who see fewer patients tend to get higher satisfaction ratings than those with higher-volume practices. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: care, perception, quality, satisfaction, urologist | 5 Comments »
Earlier this year the American Society for Clinical Oncology (ASCO) worked with the Harris Poll to put in place ASCO’s first annual National Cancer Opinion Survey. We thought many of our readers might be interested in the findings. … READ MORE …
Filed under: Uncategorized | Tagged: American, cancer, perception, public | Leave a comment »
There is growing recognition that the patient’s satisfaction or regret with his treatment decision is more than just a matter of whether he is happy with the oncological outcome. Satisfaction/regret is the product of many variables, including how well he understood his options, his interactions with his doctors, the side effects he suffered and when he suffered them, his expectations about the side effects of treatment, and cultural factors. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: HDR-BT, IMRT, perception, radiation, regret, satisfaction, SBRT, value | 1 Comment »
Healthcare and medicine have started to become engaged in what is liable to be a long and complex discussion about the “value” of different aspects of healthcare delivery. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: care, perception, value | Leave a comment »
This week’s issue of The Lancet Oncology carries an interesting editorial entitled “Perceptions of cancer in society must change.” It’s well worth a read. And the full text is available on line. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Diagnosis, life, media, perception, public | 3 Comments »
We have noted previously that individualized genetic tests sold directly to consumers and patients as tools to assess risk for prostate cancer (and other disorders) often don’t meet FDA guidelines for marketing in the USA. Now there are more questions about the value of such tests. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: behavior, direct to consumer, genetic, perception, risk, test | Leave a comment »
The following is the full text of an article by Anne Katz, RN, PhD, who is a Clinical Nurse Specialist and AASECT-Certified Sexuality Counselor who blogs at ASCO Connection, where this post originally appeared. It is reproduced here with the kind permission of the American Society for Clinical Oncology. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: decisions, perception, sex, Treatment | 17 Comments »
A new article on the Medscape web site, based on an article by Kim et al. in the journal Medical Care, deals with urologists’ and radiation oncologists’ recommendations for active surveillance (AS) as an appropriate form of treatment for low-risk prostate cancer in the USA today. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: active surveillance, perception, recommendation, value | 2 Comments »
Although it has nothing to do with prostate cancer in particular, there is an interesting article in this week’s issue of the New England Journal of Medicine that assesses how physicians interpret the published results of clinical trials of new drugs — based on the quality of the trials (their “rigor”) and who put up the money to carry the trial out (“funding”). … READ MORE …
Filed under: Uncategorized | Tagged: funding, interpretation, perception, quality, rigor, trial | Leave a comment »
We aren’t sure exactly what this adds to the recent conversations, but Gallup, the market research firm, has just provided results of a poll that asked 1,102 upstanding American adults for their opinions about cancer screening. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Gallup, opinion, perception, public, screening | 9 Comments »
It is fascinating how misinformation can drive the way we react to health care issues — and just how much misinformation we manage to propagate on a regular basis. … READ MORE …
Filed under: Uncategorized | Tagged: belief, delusion, fear, misinformation, perception | Leave a comment »
A paper in the July issue of Psychological Science addresses the influence of men’s perceptions on their willingness to be tested for prostate cancer (at least in one part of Germany). … READ MORE …
Filed under: Diagnosis, Risk, Uncategorized | Tagged: incidence, perception, risk, screening, testing | Leave a comment »
As Leah wrote in a comment on this blog just the other day, “Yes, the ‘D-word’ is still taboo. Death is UNAMERICAN.” The comment stimulated the thought that our preconceptions have significant impact on how we think about risk, diagnosis, and treatment of prostate cancer — and yet there is really very little good research on this topic. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: decision-making, knowledge, Management, perception, Treatment | 26 Comments »
… and we suspect that a similar study, if carried out in the USA, would come to similar conclusions. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: mortality, perception, risk, screening | 10 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 